Cipher Pharmaceuticals Inc T.CPH

Q1

[Northforce13]

What a nice quarter.  These were the points of interest to me;

* Nice profit, despite large legal expense
* Resolution of Trulance liability uncertainty (unless I'm mistaken)
* Bought back a respectable amount of shares
* No debt
* Positive, growing net cash balance sheet.  This gives them lots of options.

If this thing didn't have a quoted share price, or if I didn't know what it was and had to guess what it is, I would guesstimate it at around 3.50. 

Still feels very, very undervalued for a pharmaceutical.  

Today's share price action was pretty weird, was around 1.30s to 1.40s then in the close it jumped to 1.60.  I wonder if there was a fat finger trade at work, or if someone caught wind of the earnings release numbers and thought highly of them.   The fat finger thesis is a bit questionable because it was a lot of seperate trades with a bit of a time spread between them.  Hrm.  

I wonder if we will see it sail > 2.00.

Sitting on a respectable sized pile here, I like the company, fun to own and see what is going to happen.  

GLTA

[Stocker46]

Negatives: Net Earnings (after adusting for Trulance) was significantly less than 4th Q 2020 (which tends to be their strongest quarter) Positives: Trulance (we hope) is now over & done with. Generated $4.3M in Cash ending the Q with $13.3M US Dollars No Debt .. this time last year they had about $6M in Debt. Will be intesting to see how the market reacts tomorrow. And yes, some strange

[Northforce13]

After scratching my head a bit, another positive is that I expected earnings to start declining this quarter, and subsequent ones, until something comes along down the road.  Yet earnings were much stronger than expected, excluding the legal costs. The big share price jump appears to have been the result of someone with RBC as a broker sucking up shares aggressively at 1.40+ as of 3:00 PM

[GJS471]

I also liked the quarter, and the cash position.  But there is something about the strategy that still bothers me a bit when I look at the sales period over period.   While slow and steady can be a winning strategy, there needs to be something more to growth before we will see the company reach closer to its potential.  And then of course there is always the possibility of

[Stocker46]

Was hoping not but basically assumed the market reaction wouldn't be very enthusiastic. Ignoring Trulance they had about half the earnings as in 4 Q. The late trades yesterday at $1.60 make it look worse ... & the SP may improve as the day goes on. Did anyone listen to the conference call?

[stockfy]

Well said. Where are now those cluless posters of this board who blindly followed a clueless analyst Justin Keywood from Stifel and his highly inaccurate forecasts? Where are now the clueless posters who blindly used Keywood's highly inaccurate projections as BIBLE and dumped CPH at $0.90 and $0.80 a few months ago?